On international cost-sharing of pharmaceutical R&D
Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for most of drug reimbursement. By incorporating t...
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2010
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/2512 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/2512 |